Literature DB >> 8572112

Adenomatous lesions of the temporal bone immunohistochemical analysis and theories of histogenesis.

E L Bold1, J R Wanamaker, G B Hughes, C K Rhee, B A Sebek, S E Kinney.   

Abstract

Adenomatous lesions of the temporal bone represent a diverse group of neoplasms. At least three histopathologic patterns have been described: glandular; ribbon-like, or "festooning;" and aggressive papillary. Combinations of glandular and ribbon-like histologies in the same lesion are not uncommon. The glandular and ribbon-like histologies have been associated with carcinoid tumors, and the aggressive papillary tumor has been considered a separate entity. Recently, the endolymphatic sac has been proposed as the site of origin of the aggressive papillary lesions. Previous reports have described neuroendocrine properties with characteristics embracing the three histologic types. The authors postulate that the neural crest is the site of origin of this unusual group of neoplasms. Immunohistochemical analysis on the pathologic specimens of patients with adenomatous lesions of the temporal bone was performed to test this hypothesis. From 1975 to 1992 seven patients were treated at the Cleveland Clinic Foundation with a diagnosis of middle ear adenoma. A panel of special stains for neuroectodermal markers, including synaptophysin, chromogranin, neuron specific enolase, calcitonin, and serotonin was used on the paraffin-embedded formalin-fixed specimens. Three lesions were also evaluated by electron microscopy, all demonstrating dense core, intracytoplasmic granules. Three ribbon-like tumors were positive for synaptophysin and chromogranin, and two of these were positive for serotonin. One glandular tumor was positive for synaptophysin, and an aggressive papillary tumor was positive for synaptophysin and neuron specific enolase. An additional papillary tumor was referred following a third recurrence without accompanying immunohistochemical data. Cholesteatoma-like material was identified with a few glandular cells interspersed, all negative by immunohistochemical evaluation. The seventh specimen, initially diagnosed as papillary adenoma on light microscopy, was not studied by the aforementioned stains, and was later identified as a papilloma of sinonasal origin. The neural crest gives rise to pluripotential stem cells with widespread anatomic distribution, including the temporal bone. Because immunomarkers used in this study are specific for neuroectodermal differentiation, results suggest that temporal bone adenomas have neuroendocrine characteristics and could be derived from the specialized neuroectoderm of the neural crest.

Entities:  

Mesh:

Year:  1995        PMID: 8572112

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

Review 1.  Schneiderian-Type Papilloma of the Middle Ear: A Review of the Literature.

Authors:  Nathan Schaefer; Jessica Chong; Aaron Griffin; Andrew Little; Peter Gochee; Natalie Dixon
Journal:  Int Surg       Date:  2015-01-07

2.  Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions.

Authors:  M Duderstadt; Christine Förster; H-J Welkoborsky; H Ostertag
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-24       Impact factor: 2.503

3.  Papillary tumor of the temporal bone.

Authors:  B Schick; H Kronsbein; G Kahle; A Prescher; W Draf
Journal:  Skull Base       Date:  2001-02

Review 4.  Middle Ear and Temporal Bone Papilloma: A Clinicopathologic Study and Comprehensive Literature Review of 57 Cases.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2021-05-21

5.  Aggressive low grade middle ear adenocarcinoma with multiple recurrences: a case report.

Authors:  Nadia G Elhefnawy
Journal:  Diagn Pathol       Date:  2011-07-07       Impact factor: 2.644

6.  A rare case of endolymphatic sac tumour: clinicopathologic study and surgical management.

Authors:  Emanuele Ferri; Maurizio Amadori; Enrico Armato; Ida Pavon
Journal:  Case Rep Otolaryngol       Date:  2014-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.